The HealthTech Signal
At-home semen analysis is turning a taboo test into a routine one
At-home semen analysis is turning a taboo test into a routine one
Dr. Dereck Mush, MD, MBA
What they do
Tiny Health offers at-home gut microbiome tests for babies, children and adults plus a vaginal microbiome test, with practitioner tools and the Powered by Tiny partner platform. On September 29, 2026 it announced a $33 million Series B led by B Capital, bringing total funding to $46 million, alongside a $5 million Microbiome Research Program and its TinyAI engine. Founder and CEO is Cheryl Sew Hoy.
The record
- Vertical
- Primary & Virtual Care
- Sub-segment
- Microbiome testing
- Product type
- Consumer health
- Stage
- Series B
- Headquarters
- Austin, TX, USA
- Region
- North America
- Founded
- Not disclosed
- Total funding
- $46M raised
Notable investors: B Capital, Spero Ventures, The Venture City, Overwater Ventures, Black Opal Ventures, Alumni Ventures.
Also in Primary & Virtual Care
Related on The Signal
Dr. Dereck Mush, MD, MBA
The $1 Billion Bet on Pre-Symptomatic Medicine: Who Will Own the Longitudinal Baseline?
Dr. Dereck Mush, MD, MBA
Digital fertility navigation platforms are cutting the time it takes to get a diagnosis
Dr. Dereck Mush, MD, MBA
Self collection cervical screening kits are moving from pilot to mainstream option
Dr. Dereck Mush, MD, MBA